EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Mechanisms of Antiviral Agents against Dengue Virus

Michelle Felicia Lee, Yuan Seng Wu, Chit Laa Poh iD

Viruses · 08.03.2023 · 15 (3) · 705

DOI: 10.3390/v15030705 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 08.03.2023. Verfasst von Michelle Felicia Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Virus and Vaccine Research, School of Medical and Life Sciences, Sunway University, No. 5, Jalan Universiti, Bandar Sunway 47500, Selangor…. Hauptthemen laut MEDLINE: Dengue Virus, Dengue, Hepatitis C, Chronic. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 245 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Grant Scheme, Centre for Virus and Vaccine Research (CVVR), School of Medical and Life Sciences, Sunway University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue is a major global health threat causing 390 million dengue infections and 25,000 deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of a clinically approved antiviral against dengue virus (DENV) drive the urgent demand for the development of novel anti-DENV therapeutics. Various antiviral agents have been developed and investigated for their anti-DENV activities. This review discusses the mechanisms of action employed by various antiviral agents against DENV. The development of host-directed antivirals targeting host receptors and direct-acting antivirals targeting DENV structural and non-structural proteins are reviewed. In addition, the development of antivirals that target different stages during post-infection such as viral replication, viral maturation, and viral assembly are reviewed. Antiviral agents designed based on these molecular mechanisms of action could lead to the discovery and development of novel anti-DENV therapeutics for the treatment of dengue infections. Evaluations of combinations of antiviral drugs with different mechanisms of action could also lead to the development of synergistic drug combinations for the treatment of dengue at any stage of the infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusDengueHepatitis C, ChronicHumansAntiviral AgentsVirus Replication

Stichwörter der Autor:innen

antiviraldengue virusflavivirusmechanism of actionpeptidephytochemicalssmall molecule

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Centre for Virus and Vaccine Research, School of Medical and Life Sciences, Sunway University, No. 5, Jalan Universiti, Bandar Sunway 47500, Selangor, Malaysia.

ORCID-Profile: Chit Laa Poh

Förderung

  • Fundamental Research Grant Scheme
  • Centre for Virus and Vaccine Research (CVVR), School of Medical and Life Sciences, Sunway University

Zitieren

APA

Lee, M. F., Wu, Y. S., & Poh, C. L. (2023). Molecular Mechanisms of Antiviral Agents against Dengue Virus. Viruses, 15(3), 705. https://doi.org/10.3390/v15030705

Vancouver

Lee MF, Wu YS, Poh CL. Molecular Mechanisms of Antiviral Agents against Dengue Virus. Viruses. 2023;15(3):705. doi:10.3390/v15030705

BibTeX
@article{Lee2023,
  author = {Lee, Michelle Felicia and Wu, Yuan Seng and Poh, Chit Laa},
  title = {Molecular Mechanisms of Antiviral Agents against Dengue Virus},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {705},
  doi = {10.3390/v15030705}
}
Kostenlos starten →